John Bishop - Cepheid Chairman

Chairman

Mr. John L. Bishop is Chairman of the Board Chief Executive Officer and a director of Capheid. Mr. Bishop joined us as Chief Executive Officer and as a director in April 2002 and became the Chairman of the Board of Directors in February 2013. Mr. Bishop served as President and a director of Vysis Inc. a genomic disease management company that was acquired by Abbott from 1993 to 2002 and as Chief Executive Officer from 1996 to 2002. From 1991 until 1993 Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation a biotechnology company and from 1987 until 1991 of Source Scientific Systems a biomedical instrument manufacturing company. From 1984 to 1986 Mr. Bishop was President and Chief Operating Officer of GenProbe From 1968 to 1984 Mr. Bishop held various management positions with American Hospital Supply Company and its affiliates including a threeyear assignment in Japan as an Executive Vice President and Chief Executive Officer of International Reagents Corporationration a joint venture between American Hospital Supply Company and Green Cross Corporation since 2013.
Age 70
Tenure 11 years
Phone408 541-4191
Webwww.cepheid.com
Bishop served as a director of Conceptus, Inc. and a member of its compensation committee until its acquisition by Bayer HealthCare LLC in June 2013. In addition, he was a member of the AdvaMed Dx Board, since 2010, was elected Chairman of the Board in December 2013, and has served as a director of Veracyte, Inc., since November 2014.

Cepheid Management Efficiency

The company has return on total asset (ROA) of (0.0746) % which means that it has lost $0.0746 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (16.6296) %, meaning that it created substantial loss on money invested by shareholders. Cepheid's management efficiency ratios could be used to measure how well Cepheid manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 281.63 M in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Cepheid has a current ratio of 4.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cepheid until it has trouble settling it off, either with new capital or with free cash flow. So, Cepheid's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cepheid sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cepheid to invest in growth at high rates of return. When we think about Cepheid's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 10 records

CHAIRMAN Age

Youngsuk ChiRelx PLC ADR
N/A
Robert DeVincenziUniversal Technical Institute
61
John SottileVisionary Education Technology
70
Robert KellerAcco Brands
67
Neil SorahanRyanair Holdings PLC
53
Anthony HabgoodRelx PLC ADR
71
Paul WalkerRelx PLC ADR
63
Peng OuSunlands Technology Group
46
David BondermanRyanair Holdings PLC
75
Mark EinLindblad Expeditions Holdings
53
Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical and nonclinical markets. Cepheid (CPHD) is traded on NASDAQ Exchange in USA and employs 1,700 people.

Management Performance

Cepheid Leadership Team

Elected by the shareholders, the Cepheid's board of directors comprises two types of representatives: Cepheid inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cepheid. The board's role is to monitor Cepheid's management team and ensure that shareholders' interests are well served. Cepheid's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cepheid's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Gutshall, Co-Founder, Director, Member of Nominating and Governance Committee and Member of Compensation and Organizational Devel. Committee
Robert Easton, Independent Director
Glenn Steele, Independent Director
Thomas Brown, Independent Director
Warren Kocmond, COO and Executive VP
Jacquie Ross, IR Contact Officer
Kerry Flom, Chief Regulatory Officer and Executive VP
Daniel Madden, Vice President Corporate Controller and Acting CFO
Michael Fitzgerald, Executive VP of Global HR
Peter Farrell, Executive VP of Worldwide Commercial Operations
David Persing, Executive Vice President Chief Medical and Technology Officer, Director
Scott Campbell, Corporate Vice President , Chief Regulatory Officer
Marc Haugen, Executive Vice President - Engineering and Operations
John Bishop, Chairman, CEO and Member of Equity Incentive Committee
Cristina Kepner, Lead Independent Director
Hollings Renton, Independent Director
Joseph Smith, Executive Vice President - Corporate Development, General Counsel

Cepheid Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cepheid a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cepheid in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cepheid's short interest history, or implied volatility extrapolated from Cepheid options trading.

Pair Trading with Cepheid

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cepheid position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cepheid will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to United Parcel could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace United Parcel when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back United Parcel - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling United Parcel Service to buy it.
The correlation of United Parcel is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as United Parcel moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if United Parcel Service moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for United Parcel can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Cepheid information on this page should be used as a complementary analysis to other Cepheid's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Cepheid Stock

If you are still planning to invest in Cepheid check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cepheid's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years